BELX Biopharmaceuticals is a research and development biotech company, aiming at developing botanical new drugs to treat tumors and chronical liver diseases. The company is playing a leadership role in Taiwan and aspires to contribute its best efforts to improve the medical and healthcare benefits for humankind.
Complete botanical drug development platform, including GACP plantation, medicinal plant DNA sequencing, PIC/s-GMP manufacturing, bioactivity assays, pharmacology research, human clinical trials.
Chronicle Hepatitis B Infection；Cancer Cachexia
Almost 60 global patent applications,
Phase I clinical trial completed；Phase II clinical trial for chronicle hepatitis B to be stared soon
Copyright (c) 2020 BELX Bio-Pharmaceutical (Taiwan) Corporation. All rights reserved